Jeonjin Bio Co

Jeonjin Bio Co Equity

The The Equity of Jeonjin Bio Co (110020.KQ) as of Oct 16, 2026 is 17.41 B KRW. In the previous year, The Equity was 17.66 B KRW — a change of -1.43% (lower).

Equity

17.41 BKRW

YoY

-1.43%

Last updated:

In 2025, Jeonjin Bio Co's equity was 17.41 B KRW, a -1.43% increase from the 17.66 B KRW equity in the previous year.

The Jeonjin Bio Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
3.91 B KRW
Jan 1, 2019
2.90 B KRW
Jan 1, 2020
11.28 B KRW
Jan 1, 2021
10.80 B KRW
Jan 1, 2022
9.51 B KRW
Jan 1, 2023
6.22 B KRW
Jan 1, 2024
17.66 B KRW
Jan 1, 2025
17.41 B KRW
The Jeonjin Bio Co Equity history
YEAREquityYoY
17.41 BKRW-1.43%
17.66 BKRW+183.96%
6.22 BKRW-34.59%
9.51 BKRW-11.93%
10.80 BKRW-4.31%
11.28 BKRW+289.25%
2.90 BKRW-25.89%
3.91 BKRW+1,600.62%
229.96 MKRW-89.92%
2.28 BKRW+80.07%
1.27 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jeonjin Bio Co Stock analysis

What does Jeonjin Bio Co do? Jeonjin Bio Co Ltd is a South Korean company based in Daegu, operating within the Materials sector, specifically in the Chemicals industry. The company has 42 employees and went public on December 14, 2018. It is listed on the Korean stock exchange with the ticker 110020.KQ and ISIN KR7110020005. Jeonjin Bio focuses on providing products for rodent and pest control, including agents designed to reduce damage caused by birds, mammals, reptiles, pests, and parasites. The company also manufactures and sells insecticide fragrances. Its products are distributed both domestically within South Korea and internationally. The company's website is http://www.jjbio.co.kr/. Jeonjin Bio operates in the chemical sector, offering solutions for harmful animal damage reduction, with a business model centered on product manufacturing and distribution. The company has a small workforce, reflecting its focus on specialized chemical products for pest management. It is a publicly traded entity with a clear market presence in its niche sector. Jeonjin Bio Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Jeonjin Bio Co's Equity

Jeonjin Bio Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Jeonjin Bio Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Jeonjin Bio Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Jeonjin Bio Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Jeonjin Bio Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Jeonjin Bio Co stock

The Equity of Jeonjin Bio Co is 17.41 B KRW in 2025.

The Equity of Jeonjin Bio Co changed from 17.66 B KRW to 17.41 B KRW, representing a -1.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Jeonjin Bio Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Jeonjin Bio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Jeonjin Bio Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Jeonjin Bio Co